INS and polycystic ovary syndrome: For the first time, Dunaif et al. (1995[18]) suggested that excessive insulin receptor serine phosphorylation is responsible for defects in insulin action, and also shows that serine phosorylation of IRS-1 is actually increased in women with PCOS.